Nurix Receives $2,200,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=90d70b52-f749-4fd5-be8b-dee3cf76efed&Preview=1 - Date
3/29/2013 - Company Name
Nurix - Mailing Address
1700 Owens Street San Francisco, CA 94158 - Company Description
The company is focused on the discovery and development of small molecule inhibitors of ubiquitin ligases to treat a broad range of proliferative and degenerative diseases. - Website
http://www.nurix.com - Transaction Type
Venture Equity - Transaction Amount
$2,200,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds are to be used for working capital. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
